semaglutide label may reduce opioid overdoses, a new study suggests and a shorter life New Wegovy dosage was approved

Curr Obes Rep 10(4):458466 Rentzeperi E et al (2022) Sex Differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care

and potentially early insight into health system impact, e.g., cost offsets, or trends in population-level outcomes related to obesity, e.g., prevalence, morbidity or mortality

Together, they work synergistically to enhance pulsatile GH release, closely mimicking the bodys natural rhythms

In the rest of this letter for StayCurious Metabolism premium members, Ill break down: The unique metabolic state created by retatrutideincluding a novel connection I dont think anyone else has made